Afrigen proudly welcomed our colleagues from Bio Farma - Indonesia, #mRNA Technology transfer programme Indonesian partner, for their 3- week intensive training as part of the technology transfer demonstration activities. This included manufacturing drug substance and manufacturing drug product, each at 1 L (IVT) and 3.7 L scale respectively, and associated analytics. 🔬
⏭️ BioFarma photo 4: Showing their final bulk product manufactured and tested at Afrigen Biologics (Pty) Ltd.
Afrigen Biologics (Pty) Ltd
Medicines Patent Pool
World Health Organization
Bio Farma - Indonesia
#mRNA #mRNAtechnologytransfer #mRNATTProgramme #BioFarma #manufacturing #Afrigen
🔹Afrigen proudly welcomes Bio Farma- Indonesia🔹
.
#Afrigen
#mRNA
#mRNAttprogramme
#biofarma-indonesia
@afrigenbiologics @who @biofarmaid
🔹| REPOST |🔹
𝐁𝐢𝐨𝐠𝐞𝐧𝐞𝐫𝐢𝐜 𝐏𝐡𝐚𝐫𝐦𝐚 & 𝐀𝐟𝐫𝐢𝐠𝐞𝐧: 𝐀𝐝𝐯𝐚𝐧𝐜𝐢𝐧𝐠 𝐦𝐑𝐍𝐀 𝐕𝐚𝐜𝐜𝐢𝐧𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐟𝐨𝐫 𝐄𝐠𝐲𝐩𝐭 & 𝐀𝐟𝐫𝐢𝐜𝐚 🌍
We are proud to announce that on the first day of Second Vaccine manafucturing forum , Biogeneric Pharma has signed a Memorandum of Understanding (MoU) with Afrigen Biologics, marking a significant step toward strengthening vaccine manufacturing capabilities in Egypt and Africa. This milestone was achieved in the presence of our 🔹CEO Dr Mohamed Rabie, 🔹General manager Dr Heba wali, 🔹Dr Petro Terblanche CEO of Afrigen, 🔹Dr Hisham Stait Chairman of The Egyptian Authority for Unified Procurement "UPA" and 🔹Dr Hisham Badr Vice Chairman of The Egyptian Authority for Unified Procurement "UPA"
To further our commitment, both companies have agreed to sign a MoU, expanding our collaboration on #mRNA platform technology. This strategic initiative aims to tackle novel disease targets that address urgent health challenges in Egypt and the Eastern Mediterranean region.
Our focus will be on:
✅ Developing mRNA-based vaccines & therapeutics
✅ Combating antimicrobial resistance & zoonotic diseases
✅ Aligning with global health priorities in consultation with @who
This partnership represents a pivotal moment in regional healthcare innovation, paving the way for self-sufficiency in vaccine production and positioning Egypt as a key player in biotechnology and public health.
We look forward to this journey with @afrigenbiologics as we work together to drive cutting-edge solutions for global health challenges. Stay tuned for more updates!
#BiogenericPharma #Afrigen #mRNA #VaccineManufacturing #Egypt #Africa #Innovation hashtag#Healthcare #WHO #UPA
#PressRelease: South Africa’s Afrigen to develop human mRNA Rift Valley fever vaccine
🔹
💉$6.2 million CEPI funding to advance vaccine candidate through preclinical development and Phase I trials
💉Clinical testing to be completed in South Africa or another outbreak-affected country on the continent
💉Vaccine designed with the cutting-edge mRNA technology that could help rapidly respond to a future threat faster than traditional vaccines
💉Rift Valley fever is a deadly mosquito-borne disease affecting Africa and the Middle East
20 January 2025, DAVOS, SWITZERLAND—The South African biotechnology company Afrigen Biologics is pursuing pioneering new research which aims to develop the first-ever mRNA-based vaccine against Rift Valley fever, a mosquito-borne disease affecting countries across Africa and the Middle East.
Read more: https://www.afrigen.co.za/news-press-release-events/
#Afrigen #vaccine #mRNA
🌟 Grateful for Our Amazing Afrigen Team & Community! 🌟
As the year comes to a close, we want to thank our incredible team for their hard work, dedication, and passion. 💼👏 Your resilience and commitment have turned challenges into successes, and we couldn’t be prouder of what we’ve accomplished together.
We also extend our heartfelt gratitude to our partners, collaborators, funders, friends, and colleagues around the globe. Your support and friendship have been invaluable, and we wish you a joyful and blessed festive season! 🎄✨
Here’s to celebrating this year’s achievements and embracing a brighter year ahead. Thank you for being part of our journey! 🎉💪
#Teamwork #Gratitude #AfrigenSuccess #FestiveWishes
Afrigen proudly welcomed our colleagues from Biological E. Limited, mRNA Technology transfer programme Indian partner, for their 3- week intensive training as part of the technology transfer demonstration activities. This included manufacturing drug substance and manufacturing drug product, each at 100 mL scale, and associated analytics.
Picture 5 is showing the final bulk product manufactured and tested at Afrigen.
#Afrigen
#mRNA
#mRNAttprogramme
#producttested
@World Health Organization (WHO)
@Afrigen
@Biological E. Limited
@Medicines Patent Pool
Afrigen proudly welcomes Biological E. Limited, India.
World Health Organization
Medicines Patent Pool
Afrigen Biologics (Pty) Ltd
Biological E. Limited
#Afrigen
#mRNA
#mNRATechnologyTransferProgramme
Africa is home to some of the brightest minds who have not only excelled in their respective fields but have also made remarkable contributions to global progress. From groundbreaking scientific discoveries and innovations to leading transformative social and political movements, these individuals represent the pinnacle of intellectual brilliance.
⏬
Read more about our Managing Director, Professor Petro Terblanche!
https://businessday.ng/news/article/meet-9-influential-africans-report/
#Afrigenproud
#Afrigen
#biotechnology
#mNRA
Showing the final bulk product manufactured at #Afrigen.
🔹 🔬 🔹 🧪🔹
#Afrigenbiologics
#mRNA
#technologytransfer
#manufacturing
🔹
Medicines Patent Pool
World Health Organization
SINERGIUM Biotech
#Afrigen proudly welcomed our colleagues from Sinergium Biotech, #mRNA Technology transfer programme Argentinian partner, for their 3- week intensive training as part of the technology transfer demonstration activities. This included manufacturing drug substance and manufacturing drug product, each at 100 mL scale, and associated analytics.
🔹 🔬 🔹 🧪🔹
#Afrigenbiologics
#mRNA
#technologytransfer
#manufacturing
🔹
@who @sinergiumbiotech @medicinepatentpool
MRNA Technology Webinar with Dr. C Fenner ⏬
Click on the link to watch the video: https://www.youtube.com/watch?v=SBT9zGZi-Lc
🔹 Dr. Caryn Fenner, Executive Director of the mRNA Hub, Afrigen Biologics (Pty) Ltd will be discussing about mRNA technology platform development for Low- or Middle-Income Country (LMIC): The Afrigen case-study. Dr. Fenner has experience in bio manufacturing of recombinant proteins and therapeutics.
Most recently Caryn has taken on the executive directorship of the Global mRNA technology development and transfer program, a WHO-led public/ private partnership consortium to advance mRNA vaccine development and manufacturing for Africa and other Low- or Middle-Income Countries (LMIC). 🔹
#mRNAtechnology
#afrigenbiologics
#mRNAvaccine
🔹 Afrigen is honoured to participate in the World Bio Summit in Seoul, South Korea, championing bio-innovation for a better world. 🔹
#afrigen
#worldbiosummit
#bio-innovation
#betterworld
🔹 Afrigen proudly welcomes Sinergium Biotech, Argentina.🇦🇷
World Health Organization
Medicines Patent Pool
Afrigen Biologics (Pty) Ltd
SINERGIUM Biotech
#Afrigen
#mRNA
#mNRATechnologyTransferProgramme
Let`s join Dr Caryn Fenner this Friday at the 7th Vaccinology Webinar.
🔹mRNA technology platform development for LMIC: The Afrigen case-study🔹
Click here to register ⏬
https://events.teams.microsoft.com/event/b30edddf-3073-4828-8940-ac4737ec4e96@a5c0a820-c887-4727-ac66-403237d8c389
#afrigen
#afrigenbiologics
#mNRAhub
#casestudy
Afrigen proudly welcomes our colleagues from Institute Torlak, #mRNA Technology transfer programme Serbian partner, for 3- week intensive training as part of the technology transfer demonstration activities. This includes manufacturing drug substance and manufacturing drug product, each at 100 mL scale, and associated analytics.
#Afrigen
#mRNA
#mRNAtechnologytransferprogramme
#manufacturing
Afrigen Biologics (Pty) Ltd MedicinesPatentPool World Health Organization Institute of Virology, Vaccines and Sera “Torlak”
Afrigen is growing, and we have exciting job opportunities available. Visit https://www.afrigen.co.za/vacancies/ to find out more.
IMPORTANT LINKS 🔗 IN PROFILE INFO ⬆️
#Afrigen
Afrigen Biologics proud to be associated with the International Society Society for Vaccines (ISV) and to support the annual conference in Seoul, South Korea on 21 to 23 October.
#Afrigen
#ISV
#vaccines
Let`s join Petro Terblanche - They will be discussing the latest trends, challenges and opportunities for life hashtag#science at BIO-Europe. Celebrating 30 years of facilitating partnerships, this year`s event is not one to miss.
Register to join: https://lnkd.in/dB8FK388
Informa Connect
Afrigen Biologics
Don’t miss @USPharmacopeia’s session tomorrow at #DCVMNAGM to hear Laura Martin and Petro Terblanche discuss ways to build regulatory capacity for vaccine approval for market use, highlighting experiences from African manufacturers.
⏩ Learn more: https://ow.ly/7oj450TIQ1z
#Afrigen
#vaccines
#manufacturers
Update on the #mRNA Technology Transfer Programme.
--The mRNA Technology Transfer Programme, established by the World Health Organization (WHO) in partnership with the Medicines Patent Pool (MPP), was launched in July 2021 in response to the COVID-19 pandemic to address the global inequities in vaccine manufacturing. Its primary aim is to build mRNA vaccine manufacturing capacity in low- and middle-income countries (LMICs), thus bolstering health security through local and regional production.--
Click here to read more ▶️https://healthpolicy-watch.news/update-on-the-mrna-technology-transfer-programme/
#mRNA
#mNRATechologyTransferProgramme
#Afrigen
Preclinical evaluation in hamster model of the #mRNA COVID-19 vaccine candidate AfriVac 2121 (Wuhan) produced under the WHO/MPP mRNA Technology Transfer Programme.
▶️ Read more: https://www.afrigen.co.za/2024/10/09/preclinical-evaluation-in-hamster-model-of-the-mrna-covid-19-vaccine-candidate-afrivac-2121-wuhan-produced-under-the-who-mpp-mrna-technology-transfer-programme/
#mRNA
#mRNAtechnologytransferprogramme
#Afrigen
#WHO
#MPP
© 2018 All rights reserved
CREATED BY JANE-EYE CREATIVE
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |